Brief: Lal Pathlabs To Buy 100% Stake In Shahbazkers Diagnostic Centre
30/04/2026 11:13
April 30 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS: LAL PATHLABS - TO BUY 100% STAKE IN SHAHBAZKERS DIAGNOSTIC CENTRE LAL PATHLABS - TO INCORPORATE WHOLLY OWNED SUBSIDIARY IN DUBAI, UAE LAL PATHLABS - RE-APPOINTS ARVIND LAL AS EXECUTIVE CHAIRMAN FROM APRIL 2027 Source text: ID:nNSE7hGmYk Further company coverage: DLPA.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise